Your session is about to expire
← Back to Search
Device
GARNET device for Bloodstream Infection
N/A
Waitlist Available
Research Sponsored by Boa Biomedical, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30-day follow-up post-2nd garnet device treatment
Awards & highlights
Study Summary
This study is evaluating whether a new device which combines hemodialysis and antibiotics may help treat patients with blood stream infections.
Eligible Conditions
- Bloodstream Infection
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30-day follow-up post-2nd garnet device treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30-day follow-up post-2nd garnet device treatment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Safety - Rate of adjudicated device- or GARNET device procedure-related Serious Adverse Events (SAEs)
Secondary outcome measures
Clearance for small (blood urea nitrogen) and middle (beta-2-microglobulin) molecule solutes by the GARNET device, as measured by the intra-dialytic urea and beta-2-microglobulin reduction ratio.
Resolution of Blood Stream Infection at 30-days post 2nd GARNET device treatment
Trial Design
1Treatment groups
Experimental Treatment
Group I: GARNET deviceExperimental Treatment1 Intervention
All enrolled subjects will receive treatment with the GARNET device.
Find a Location
Who is running the clinical trial?
Boa Biomedical, Inc.Lead Sponsor
AvaniaIndustry Sponsor
46 Previous Clinical Trials
8,883 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger